Quick Answer
HNO International, Inc. reported Diluted EPS of $0.04 per share (loss) for fiscal year 2025.
HNO International, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.04 | -300.0% |
| 2024 | -$0.01 | +0.0% |
| 2023 | -$0.01 | +0.0% |
| 2022 | -$0.01 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | $0.00 | +100.0% | +100.0% |
| July 31, 2025 | -$0.01 | — | +0.0% |
| April 30, 2025 | -$0.01 | — | +50.0% |
| January 31, 2025 | -$0.02 | — | — |
| July 31, 2024 | $0.00 | — | — |
| April 30, 2024 | $0.00 | — | — |
| January 31, 2024 | $0.00 | — | — |
| July 31, 2023 | $0.00 | — | — |
- HNO International, Inc. showed a decrease of -300.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2022–2025 period, HNO International, Inc.’s diluted eps has declined by 300.0% (from $0.01 per share (loss) to $0.04 per share (loss)).
- The most recent figure is from HNO International, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: